| Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clinical infectious diseases 46 (12), 1813-1821, 2008 | 5641 | 2008 |
| Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America TJ Walsh, EJ Anaissie, DW Denning, R Herbrecht, DP Kontoyiannis, ... Clinical infectious diseases 46 (3), 327-360, 2008 | 3596 | 2008 |
| Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus S Ascioglu, JH Rex, B De Pauw, JE Bennett, J Bille, F Crokaert, ... Проблемы медицинской микологии 5 (1), 10-16, 2003 | 2903 | 2003 |
| Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ... Clinical infectious diseases 63 (4), e1-e60, 2016 | 2833 | 2016 |
| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1447 | 2019 |
| Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria R Agarwal, A Chakrabarti, A Shah, D Gupta, JF Meis, R Guleria, R Moss, ... Clinical & Experimental Allergy 43 (8), 850-873, 2013 | 895 | 2013 |
| Allergic bronchopulmonary aspergillosis in cystic fibrosis—state of the art: Cystic Fibrosis Foundation Consensus Conference DA Stevens, RB Moss, VP Kurup, AP Knutsen, P Greenberger, ... Clinical Infectious Diseases 37 (Supplement_3), S225-S264, 2003 | 837 | 2003 |
| Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy J Maertens, I Raad, G Petrikkos, M Boogaerts, D Selleslag, FB Petersen, ... Clinical Infectious Diseases 39 (11), 1563-1571, 2004 | 798 | 2004 |
| Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance P Koehler, M Bassetti, A Chakrabarti, SCA Chen, AL Colombo, M Hoenigl, ... The Lancet Infectious Diseases 21 (6), e149-e162, 2021 | 761 | 2021 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 731 | 2014 |
| NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis DW Denning, JY Lee, JS Hostetler, P Pappas, CA Kauffman, ... The American journal of medicine 97 (2), 135-144, 1994 | 587 | 1994 |
| Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy FK Gould, DW Denning, TSJ Elliott, J Foweraker, JD Perry, ... Journal of antimicrobial chemotherapy 67 (2), 269-289, 2012 | 584 | 2012 |
| ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ... Clinical Microbiology and Infection 20, 27-46, 2014 | 473 | 2014 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 452 | 2021 |
| Multicenter epidemiologic study of coronavirus disease–associated mucormycosis, India A Patel, R Agarwal, SM Rudramurthy, M Shevkani, I Xess, R Sharma, ... Emerging infectious diseases 27 (9), 2349, 2021 | 434 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 339 | 2021 |
| An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome DW Denning, A Marinus, J Cohen, D Spence, R Herbrecht, L Pagano, ... Journal of Infection 37 (2), 173-180, 1998 | 338 | 1998 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi A Chowdhary, JF Meis, J Guarro, GS De Hoog, S Kathuria, MC Arendrup, ... Clinical Microbiology and Infection 20, 47-75, 2014 | 318 | 2014 |
| Invasive zygomycosis in India: experience in a tertiary care hospital A Chakrabarti, SS Chatterjee, A Das, N Panda, MR Shivaprakash, A Kaur, ... Postgraduate medical journal 85 (1009), 573-581, 2009 | 265 | 2009 |
| Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study BH Tan, A Chakrabarti, RY Li, AK Patel, SP Watcharananan, Z Liu, ... Clinical Microbiology and Infection 21 (10), 946-953, 2015 | 167 | 2015 |
